|
|
Article: Reports outline neuropathic pain therapy study results from J.P. Lefaucheur et al.
- Article from:
- Virus Weekly
- Article date:
- June 9, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A new study, 'Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain,' is now available. According to recent research from France, "Epidural motor cortex stimulation (MCS) has been proposed as a treatment for chronic, drug-resistant neuropathic pain of various origins. Regarding pain syndromes due to peripheral nerve lesion, only case series have previously been reported."
"We present the results of the first randomized controlled trial using chronic MCS in this indication. Sixteen patients were included with pain origin as follows: trigeminal neuralgia (n=4), brachial plexus lesion (n=4), neurofibromatosis type-1 (n=3), upper limb ...